The global precision nutrition market is projected to reach USD 12.89 billion by 2029, growing from an estimated USD 6.09 billion in 2024 at a CAGR of 16.2%. This growth is driven by increasing consumer demand for personalized health and wellness solutions, advancements in genetic and biomarker testing technologies, and greater awareness of nutrition’s role in disease prevention. The shift towards preventive healthcare, coupled with rising healthcare costs, has further propelled the adoption of precision nutrition. The integration of artificial intelligence and analytics in dietary recommendations, along with strategic collaborations among technology providers, healthcare professionals, and nutrition companies, is driving market expansion. Trends such as microbiome-based nutrition and customized supplements are also fueling market growth.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=2370137
Genomics Leading Market Share During the Forecast Period
Genomics holds the largest market share within the precision nutrition technology segment due to its ability to provide highly personalized insights into an individual’s genetic makeup. By analyzing genetic variations, companies can offer tailored nutritional advice to optimize metabolism, reduce disease risk, and improve overall wellness. The growing popularity of home testing kits like 23andMe and Ancestry has driven demand for genomics-based personalized nutrition solutions. Genomics enables a focused approach to nutrition, leveraging genetic predispositions for conditions such as obesity, diabetes, and cardiovascular disease to create precise dietary interventions. The combination of genomics with other technologies, such as AI and microbiome analysis, enhances its ability to deliver actionable health insights. This technology segment continues to lead the market with scalable, data-rich solutions that cater to individual health needs, making genomics a key driver for innovation and market growth.
Disease Management Anticipated to Grow at the Highest Rate
The disease management segment is expected to experience the highest growth due to the increasing adoption of personalized dietary interventions for chronic and lifestyle-related conditions. Precision nutrition allows for highly targeted recommendations for specific health issues, including diabetes, cardiovascular diseases, obesity, and gastrointestinal disorders, utilizing genetic, biomarker, and lifestyle data analysis. Advances in AI, genomics, and microbiome analysis are enhancing the development of customized solutions for disease management. By aligning dietary recommendations with individual genetic profiles, microbiome composition, and metabolic responses, precision nutrition effectively addresses the risks associated with these diseases. Furthermore, the rise in preventive care within healthcare management necessitates the integration of personalized nutrition solutions, allowing patients to make informed dietary changes alongside medical treatments. Digital health platforms for monitoring and tracking disease-related biomarkers are playing a crucial role in improving the efficacy of these interventions, making this segment a significant area of growth within precision nutrition.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=2370137
Asia Pacific to Lead Growth with the Highest CAGR
The Asia-Pacific region is the fastest-growing market for precision nutrition, driven by increased health awareness, rising chronic disease prevalence, and advancements in genomics and digital health technologies. Growing middle-class populations with higher disposable incomes have accelerated the adoption of personalized dietary and wellness solutions. Government initiatives supporting health and nutrition innovation further contribute to this growth, particularly in countries like China, Japan, and India. Additionally, local players providing culturally adapted, cost-effective solutions are driving market expansion, alongside a shift towards preventive healthcare practices.
Leading Precision Nutrition Companies:
The report profiles key players such as Viome Life Sciences, Inc. (US), Prenetics Global Limited (China), ZOE Limited (UK), myDNA Life Australia Pty Ltd. (Australia), 23andMe, Inc. (US), DayTwo Inc (US), Nutrigenomix (Canada), Genesis Healthcare Co. (Japan), AMILI (Singapore), and SelfDecode (US).
